Karyopharm Therapeutics Inc. (KPTI) Insider Trading -- Recent Executive & Director Transactions

7 insiders reported 74 Form 4 transactions for Karyopharm Therapeutics Inc. (KPTI) over the past 18 months (most recent 2026-05-15). Recent activity: Rangwala Reshma (EVP & Chief Medical Officer) Sell 408 shares, Rangwala Reshma (EVP & Chief Medical Officer) Buy 947 shares, Mano Michael (EVP, CLO&Secretary) Buy 700 shares, Cheng Sohanya Roshan (EVP & Chief Commercial Officer) Buy 947 shares, Poulton Stuart (EVP, Chief Development Officer) Buy 896 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-05-15Rangwala ReshmaEVP & Chief Medical OfficerSell408$3,876
2026-05-15Rangwala ReshmaEVP & Chief Medical OfficerBuy947$0
2026-05-15Mano MichaelEVP, CLO&SecretaryBuy700$0
2026-05-15Cheng Sohanya RoshanEVP & Chief Commercial OfficerBuy947$0
2026-05-15Poulton StuartEVP, Chief Development OfficerBuy896$0
2026-05-15Abate KristinChief Accounting OfficerBuy121$0
2026-05-15Paulson Richard A.President and CEOSell2,203$20,928
2026-05-15Paulson Richard A.President and CEOBuy4,920$0
2026-05-15Mano MichaelEVP, CLO&SecretarySell266$2,527
2026-05-15Cheng Sohanya RoshanEVP & Chief Commercial OfficerSell324$3,078
2026-05-15Poulton StuartEVP, Chief Development OfficerSell403$3,828
2026-05-15Abate KristinChief Accounting OfficerSell53$504
2026-04-22Rangwala ReshmaEVP & Chief Medical OfficerSell449$4,014
2026-03-03Cheng Sohanya RoshanEVP & Chief Commercial OfficerSell4,604$43,324
2026-03-03Rangwala ReshmaEVP & Chief Medical OfficerSell5,066$47,671
2026-03-03Abate KristinChief Accounting OfficerSell559$5,260
2026-03-03Paulson Richard A.President and CEOSell12,361$116,317
2026-03-03Mano MichaelEVP, CLO&SecretarySell3,526$33,180
2026-03-03Poulton StuartEVP, Chief Development OfficerSell5,101$48,000
2026-02-19Poulton StuartEVP, Chief Development OfficerSell378$3,262
2026-02-09Paulson Richard A.President and CEOBuy81,060$0
2026-02-04Macomber LoriEVP, CFO & TreasurerSell1,626$10,244
2026-02-03Mano MichaelEVP, CLO&SecretaryBuy32,415$0
2026-02-03Poulton StuartEVP, Chief Development OfficerBuy32,415$0
2026-02-03Cheng Sohanya RoshanEVP & Chief Commercial OfficerBuy32,415$0

Source: SEC Form 4 filings · as of 2026-05-15